$ODTX
Odyssey Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$18.12
▲+0.22%+$0.040
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateOdyssey Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ODTX up today? It is at $18.12 (+0.22%), and our scanner flagged it 58 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ODTX spikes, and full due diligence on ODTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ODTX 58 times in the last 30 days. Create a free account to track $ODTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ODTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ODTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystPhase 2a Monotherapy Trial Results, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Opipari Anthony W. Officer | Acquired (grant/award) | +7K 0.01% of company | n/a | 7K | n/a | May 11, 26 |
Opipari Anthony W. Officer | Sold (automatic/other) | -4 | sold <0.1% | 8K | $72 at $18.00 | May 11, 26 |
Opipari Anthony W. Officer | Other | 541 | added 7.8% | 8K | n/a | May 11, 26 |
Glick Gary D Officer | Acquired (grant/award) | +27K 0.06% of company | added 7.0% | 416K | n/a | May 11, 26 |
Chu Shelley Director | Bought (open market) | +11K 0.02% of company | n/a | 11K | $200K at $18.00 | May 11, 26 |
Li Nan (Ln) Director | Acquired (grant/award) | +1.71M 3.6% of company | added 100% | 2.22M | n/a | May 11, 26 |
Li Nan (Ln) Director | Bought (open market) | +1.11M 2.3% of company | added 50% | 3.33M | $20.0M at $18.00 | May 11, 26 |
Leiden Jeffrey M Director | Acquired (grant/award) | +29K 0.06% of company | n/a | 29K | n/a | May 11, 26 |
Leiden Jeffrey M Director | Sold (automatic/other) | -17 | sold <0.1% | 32K | $306 at $18.00 | May 11, 26 |
Leiden Jeffrey M Director | Other | 3K | added 10% | 32K | n/a | May 11, 26 |
Sr One Capital Management, Llc Beneficial Owner (10%) | Acquired (grant/award) | +2.92M 6.1% of company | n/a | 1.42M | n/a | May 11, 26 |
Sr One Capital Management, Llc Beneficial Owner (10%) | Sold (automatic/other) | -2K | sold 0.4% | 441K | $32K at $18.00 | May 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on ODTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ODTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ODTX last traded at $18.12, up 0.22% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Odyssey Therapeutics, Inc. Common Stock (ODTX) is next expected to report earnings on Wednesday, November 4, 2026, about 27 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ODTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ODTX 58 times in the last 30 days.
ODTX (Odyssey Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $871M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ODTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ODTX discussion
Sign in to ask a question or join the discussion.